Kancera AB is a biotechnology company that focuses on the development and sale of drug candidates that have the potential to cure or to stops the progression of cancer. Its activities are divided into Pharmaceutical Development and Industrial Research and Development.
| Website: | www.kancera.com |
| Main Phone: | +46 850126080 |
| Address: | Karolinska Institutet Science Park |
| Address 2: | Banvaktsvagen 22 |
| City / Town: | Solna |
| Country: | SWE |
| Postal Code: | 171 48 |
| Exchange: | GREY |
| Employees: | 20 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Kancera AB is a biotechnology company that focuses on the development and sale of drug candidates that have the potential to cure or to stops the progression of cancer. Its activities are divided into Pharmaceutical Development and Industrial Research and Development.
| Website: | www.kancera.com |
| Main Phone: | +46 850126080 |
| Address: | Karolinska Institutet Science Park |
| Address 2: | Banvaktsvagen 22 |
| City / Town: | Solna |
| Country: | SWE |
| Postal Code: | 171 48 |
| Exchange: | GREY |
| Employees: | 20 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 0.08 | Change $ 0. | Change % 0.00 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open N/A | High N/A | Low N/A | Prev Close 0.08 |
| Last Trade | Volume 0 | 52 Wk Hi 0.08 | 52 Wk Low 0.08 |
| Market Cap 16.8 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 209,825,492.00 | EPS (TTM) -0.02 | PE Ratio N/A | Exchange Greys |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait